The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells

Mattia Apollonio1, Arianna Bellazzo1, Nicoletta Franco1

  • 1Department of Life Sciences, University of Trieste, Via L. Giorgieri 1, 34127 Trieste, Italy.

Cancers
|July 14, 2023
PubMed

Insights

DAB2IP, a tumor suppressor, is sustained by cell confluency and dampens oncogenic YAP/TAZ signaling. Loss of DAB2IP in confluent cells promotes YAP/TAZ activation, potentially accelerating cancer development.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Mechanobiology

Background:

  • Mechanical forces regulate cell functions and tissue homeostasis.
  • YAP/TAZ transcriptional regulators are key in mechanical signaling and often hyperactivated in tumors.
  • DAB2IP, a tumor suppressor, negatively regulates oncogenic pathways and is often lost in cancers.

Purpose of the Study:

  • To investigate the role of DAB2IP in mechanical signaling and its relationship with YAP/TAZ.
  • To determine how cell confluency affects DAB2IP expression and function.
  • To elucidate DAB2IP's contribution to oncogenic transformation in epithelial cells.

Main Methods:

  • Studied DAB2IP expression in relation to cell confluency.
  • Assessed effects of DAB2IP depletion on cell morphology and stiffness in confluent cells.
  • Analyzed YAP/TAZ localization and activity upon changes in DAB2IP expression levels.

Main Results:

  • DAB2IP expression is maintained by cell confluency.
  • DAB2IP depletion in confluent cells led to altered morphology, reduced packing, and increased stiffness.
  • DAB2IP depletion promoted YAP/TAZ nuclear entry and activity; ectopic DAB2IP caused cytoplasmic retention of YAP/TAZ.

Conclusions:

  • DAB2IP acts as a sensor of cell interactions, suppressing YAP/TAZ in confluent cells.
  • Loss of DAB2IP function in epithelia facilitates YAP/TAZ activation, promoting oncogenic transformation.
  • DAB2IP is a potential therapeutic target for cancers with aberrant YAP/TAZ signaling.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K